| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |